Initial consult, preparatory session:
Pre-Treatment Guidelines:
Ketamine Experience:
Post Treatment:
Integration:
Parke-Davis (Pfizer) patented Ketamine in 1966 as an anesthetic in veterinary and human medicine. Ketamine was administered easily/safely by soldiers and corpsmen in the Vietnam War. It was a battlefield anesthetic, sedative, and analgesic (pain-relieving). It is the most commonly used anesthetic in pediatric surgery. Ketamine was discovered to have rapid acting antidepressant and anti-suicidal effects (2000). In 2019 Spravato, an intranasal ketamine, was FDA approved for treatment resistant depression and suicidal ideation. Ketamine is used in off-label treatment for treatment resistant depression, alcohol and other substance use disorders, PTSD, OCD and more. All psychoactive substances have risk of side effects and may affect individuals differently.
Common side effects:
Rare side effects:
Ketamine is an off-label treatment for treatment-resistant depression, alcohol and other substance use disorders, PTSD, OCD, etc.
Depression
Ketamine has a rapid/robust antidepressant effect immediately after use. It can affect remission in 2/3 of patients and reverse suicidal thinking. The antidepressant response lasts 7-days; longer in a comprehensive tx plan.
Addiction
Ketamine can achieve and sustain alcohol abstinence in alcoholics, heroin abstinence n heroin dependence, reduce cravings and decrease self administration of cocaine in clinical trials.
PTSD
Improvements were immediate w/PTSD, lasted 1-2 weeks w/o comprehensive tx.
OCD
Rapid sustained effects in patients suffering OCD.
Ketamine Assisted Psychotherapy
Preparation and integration sessions are utilized to optimize benefits. Ketamine induces neuroplasticity in new awareness, perspective, insight(s).